Single nucleotide polymorphisms of follicle-stimulating hormone receptor are associated with ovarian cancer susceptibility

被引：0
作者：
Bose, Chinmoy K. [1 ]
机构：
[1] Kolkata Municipal Corp, Dept Hlth, N Matern Home, Kolkata, India
[2] Coll Med, Dept Obstet & Gynaecol, Kolkata, India
来源：
CARCINOGENESIS | 2007年 / 28卷 / 09期
关键词：
D O I：
10.1093/carcin/bgm035
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2059 / 2059
页数：1
相关论文
共 7 条
[1]  
Bose CK, 2007, J TURK-GER GYNECOL A, V8, P76
[2]  
Bose CK, 2005, REPROD BIOMED ONLINE, V11, P194
[3]   Nerve growth factor, follicle stimulating hormone receptor and epithelial ovarian cancer [J].
Bose, CK .
MEDICAL HYPOTHESES, 2004, 63 (05) :917-918
[4]  
BOSE CK, 2006, CARCINOGENESIS, V27, P1502
[5]  
CAMPOS X, 2006, IN PRESS GYNECOL ONC
[6]   Overexpression of follicle-stimulating hormone receptor activates oncogenic pathways in preneoplastic ovarian surface epithelial cells [J].
Choi, JH ;
Choi, KC ;
Auersperg, N ;
Leung, PCK .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (11) :5508-5516
[7]   Single nucleotide polymorphisms of follicle-stimulating hormone receptor are associated with ovarian cancer susceptibility [J].
Yang, C. Q. ;
Chan, K. Y. K. ;
Ngan, H. Y. S. ;
Khoo, U. S. ;
Chiu, P. M. ;
Chan, Q. K. Y. ;
Xue, W. C. ;
Cheung, A. N. Y. .
CARCINOGENESIS, 2006, 27 (07) :1502-1506
1